Brain scans could reveal why antidepressants fail millions
NCT ID NCT03537794
Summary
This study aims to understand why some people with depression don't respond to standard medications by comparing brain scans of three groups: people with treatment-resistant depression, people whose depression responds to medication, and healthy individuals. Researchers will use MRI and PET scans to measure dopamine receptors in specific brain regions. The goal is to identify biological differences that could lead to better treatments for the 30% of depression patients who don't get better with current medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unity Health Toronto
RECRUITINGToronto, Ontario, M5B 1M4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.